Qube Research & Technologies Ltd - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,599,402
-51.0%
126,862
-52.5%
0.01%
-63.2%
Q2 2023$5,302,429
+213.8%
266,856
+170.5%
0.02%
+171.4%
Q1 2023$1,689,857
+123.5%
98,649
+79.6%
0.01%
+16.7%
Q2 2022$756,000
+52.1%
54,935
+75.3%
0.01%
+50.0%
Q1 2022$497,000
-19.6%
31,345
+10.7%
0.00%
-20.0%
Q4 2021$618,000
+2.0%
28,316
+107.4%
0.01%
-50.0%
Q1 2021$606,000
+146.3%
13,650
+26.1%
0.01%
+25.0%
Q4 2019$246,00010,8260.01%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders